Variable | Tasmania (n = 443) | Victoria (n = 456) | p |
---|---|---|---|
Sex | |||
 Male | 262 (59.1) | 244 (53.5) | 0.09 |
 Female | 181 (40.9) | 212 (46.5) | |
Age | 64 (12.9) | 70 (11.7) | < 0.0001a |
Diabetes type | |||
 Type 1 | 61 (13.8) | 22 (4.8) | < 0.0001a |
 Type 2 | 382 (86.2) | 434 (95.2) | |
Diagnosed > 20 years+ | 129 (29.6) | 93 (20.8) | 0.002a |
Current smoker | 51 (11.5) | 61 (13.4) | 0.40 |
Knowledge of ideal HbA1c target (mmol/L) | |||
  ≤ 7.5 | 224 (50.6) | 184 (40.4) | 0.002a |
  > 7.5 or don’t know | 219 (49.4) | 272 (55.4) | |
 IRSD decile (median (IQR)) | 3 (2–5) | 3 (2–4) | 0.33 |
Rurality of residence | |||
 Inner regional | 168 (37.9) | 403 (88.4) |  |
 Outer regional | 240 (54.2) | 53 (11.6) | < 0.0001a |
 Remote or very remote | 35 (7.9) | 0 (−) |  |
UT Risk Classification | |||
 No neuropathy | 159 (35.9) | 192 (42.1) | N/A |
 Neuropathy | 63 (14.2) | 86 (18.9) | |
 Neuropathy with deformity | 11 (2.5) | 74 (16.2) | |
 History of pathology | 79 (17.8) | 43 (9.4) | |
 Neuropathic ulcer | 67 (15.1) | 37 (8.1) | |
 Acute Charcot | 6 (1.4) | 2 (0.4) | |
 Infection | 19 (4.3) | 6 (1.3) | |
 Ischaemia | 39 (8.8) | 16 (3.5) | |
Consolidated UT Risk Classification | |||
 No neuropathy | 159 (35.9) | 192 (42.1) |  |
 Neuropathy/neuropathy with deformity | 74 (16.7) | 160 (35.1) | < 0.0001a |
 History of, or current, pathology | 210 (47.4) | 104 (22.8) |  |